Article

What We're Reading: Will Trump Weigh in on Healthcare?

Author(s):

An expert asks whether we'll hear more on the Republican nominee's healthcare plans, and a study shows obese kids benefit from eating less sugar.

Will Donald J. Trump talk about healthcare this week? A professor at the Drexel University School of Public Health in Philadelphia writes the Republican presidential nominee-in-waiting has been highly specific about some healthcare issues but offers few details on others. Robert I. Field, PhD, JD, MPH, writes that Trump agrees with Democrat Hillary Clinton that all Americans should have healthcare, and he shares concerns about high drug prices. But Trump has been vague on what would replace the Affordable Care Act if it was repealed.

Cutting sugar from diets of obese kids produces health benefits quickly, according to a new study reported in The New York Times. The study in Atherosclerosis examined 37 children ages 9 to 18 who were obese and at risk for heart disease and type 2 diabetes. The children were given diets with the same calories, fat, and protein as their typical diet, but with less added sugar. After 9 days, the study saw a 33% drop in triglycerides, and a 49% drop in a protein apoC-III linked to high triglyceride levels, as well as drops in low-density lipoprotein (LDL) cholesterol.

A new study from researchers at the University of Alabama at Birmingham and Johns Hopkins University finds that symptoms of chronic fatigue can be sparked with mild to moderate strain on the muscles and nerves. The study, published in the journal PLOS One, compared individuals with and without chronic fatigue who were asked to perform leg raises of different types=-some caused strain while others didn’t. Those who experienced strain and had chronic fatigue syndrome reported more symptoms the next day.

Related Videos
Mei Wei, MD.
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Sandra Cueller, PharmD
Ticiana Leal, MD
James Chambers, PhD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo